Insights

FARRIS FORWARD: How to Unlock Your Passion: The Power of “Why”

LOS ANGELES–Welcome to Farris Forward, a new series of articles by Jon Farris exploring the intersection of strategy and leadership. In the difficult and fast-paced world of business, especially in cannabis, it's easy to get caught up in the "what" and "how" of your endeavors. Companies often pride themselves on the products they make or ...

October 16th, 2023|
  • Cannabis in Food and Beverage Market

Canadian Cannabis Advocates Push for Higher THC Limits in Edibles Amid Regulatory Review

NEW YORK-  In a significant development in Canada's cannabis landscape, advocates are pressing the federal government to revise the potency limits for cannabis edibles. A petition launched last week is seeking a tenfold increase in the maximum permitted THC levels, from the current 10 milligrams per product to 100 milligrams per package. Background of Cannabis ...

November 15th, 2023|

TerrAscend Corp. Raises Revenue Guidance, Sees Robust Growth in Multiple States

LOS ANGELES-- TerrAscend Corp. displayed a strong financial posture by updating its revenue guidance for 2023 during its investor day at the Toronto Stock Exchange. This adjustment propelled the company's stock upwards by 4%, resulting in a current value of $1.91 per share. The company, showing confidence in its operational trajectory, elevated its 2023 forecast ...

October 16th, 2023|

Tilray Medical Engages in Glioblastoma Research Through Clinical Trial in Spain

LOS ANGELES-- In a significant stride for the medical cannabis community, Tilray Medical, an affiliate of Tilray Brands, Inc., declared its involvement in a groundbreaking clinical trial slated to delve into the therapeutic potential of medical cannabis against glioblastoma, a particularly aggressive variant of brain cancer. Set to be orchestrated in Spain, this clinical trial ...

October 16th, 2023|

FDA Warns Against Unsupervised Use of Ketamine for Psychiatric Disorders

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has raised concerns over the unsupervised and unauthorized use of compounded ketamine and ketamine-based drugs for treating psychiatric conditions. In a recent alert, the FDA pointed to the dangers posed by the unregulated use of such drugs, especially in the wake of the substance's growing ...

October 13th, 2023|

Canada’s Cannabis Industry Faces Economic Challenges, Says Health Canada Report

OTTAWA — A recent report by the Canadian government suggests the nation's legal cannabis industry is encountering significant economic challenges, shedding light on the realities faced by businesses after the 2018 legalization. The report, titled "What We Heard Report," was published by Health Canada on October 10th, detailing the findings of a legislative review of ...

October 13th, 2023|

ANALYSIS: Cannabis Payments: Navigating a Landscape of Opportunities and Pitfalls

NEW YORK — Cannabis payment systems have always been rife with controversy and uncertainty. As we explore the landscape, the focus is primarily on services purporting to have a compliant mechanism to accept credit cards. To be succinct, while cannabis remains federally illegal, all payment systems for it are mere workarounds. Some are safe, others ...

October 11th, 2023|

New Mexico’s Cannabis Microbusiness License Fees May Rise

NEW YORK — Cannabis microbusinesses in New Mexico may soon face a hike in their annual license fees, should proposed rule changes be ratified after a public comment period. A slated policy revision by the state Regulation and Licensing Department’s Cannabis Control Division (CCD) aims to double the annual permit fees for integrated cannabis microbusinesses ...

October 11th, 2023|

Alaska Imposes New Restrictions on Hemp Goods Industry

  LOS ANGELES— Alaska has intensified its stance on the rapidly expanding national hemp goods sector, especially targeting hemp-derived products that some locals colloquially term "diet weed." Lt. Gov. Nancy Dahlstrom inked new regulations into law last week, slated to be effective from Nov. 3. These stipulations move the purview of intoxicating hemp items to ...

October 10th, 2023|

Optimi Gains Momentum with Health Canada’s Approval for Psychedelics Supply

Toronto — Optimi, a leading Canadian psychedelics drug research and formulation enterprise, announced a pivotal achievement today. Health Canada has sanctioned an amendment to the company's Dealer's Licence, setting the stage for Optimi to commence its supply endeavours for Canada's Special Access Program (SAP). This initiative is rooted in compliance with the Controlled Drugs and ...

October 10th, 2023|

Pennsylvania Legislature Mulls Over Tax Reform Benefiting Medical Cannabis Businesses

The Pennsylvania legislature has made strides in advancing a comprehensive tax reform measure, which notably addresses a crucial obstacle faced by state-sanctioned medical cannabis entities: the IRS's 280E code. This code presently restricts these businesses from availing federal tax deductions. Approved by a narrow margin of 102-101 in a party-line House vote on Tuesday, the ...

October 10th, 2023|

New York Opens Doors for Medical Cannabis Operators to Dive into Adult-Use Retail Market

NEW YORK- In a significant move on Tuesday, New York regulators gave the nod for the state's medical marijuana entities to file applications for adult-use retail licenses. This opens the arena for multi-state operators (MSOs) holding a lion's share of the state's ten "registered organization" permits to tap into what might soon become the most ...

October 10th, 2023|

Clearmind Medicine Partners with Johns Hopkins for Psychedelic-Derived Therapeutic Trials

TEL AVIV— Clearmind Medicine Inc.  a biotech firm the charge in discovering and developing innovative psychedelic-derived treatments for significant health concerns, revealed a new collaboration today. The company has forged a Clinical Trial Agreement with the renowned Johns Hopkins University School of Medicine (JHU) to oversee its Phase I/IIa clinical evaluation of its proprietary MEAI-based ...

October 9th, 2023|

Arizona’s Cannabis Social Equity Licenses: Intent Versus Outcome

PHOENIX — The State of Arizona's well-intentioned efforts to address historical disparities in the cannabis industry appear to be veering off course. A deep dive into the allocation of social equity licenses, designed to benefit those who were adversely affected by the war on drugs, reveals that these permits might be benefiting established corporate entities ...

October 9th, 2023|

Canada’s Long-Awaited Cannabis Strategy Table Takes Shape

TORONTO — Nearly two years after its announcement, Canada's government-mandated cannabis "strategy table" is beginning to show signs of activity. The initiative, aimed at addressing core challenges faced by the nation's beleaguered cannabis industry, had been lost in bureaucratic inertia, sparking concerns among stakeholders. However, recent developments suggest a renewed momentum. The strategy table, conceived ...

October 5th, 2023|

Nationwide Inconsistencies in Cannabis Testing Raise Concerns over Consumer Safety

NEW YORK — With increasing numbers of states legalizing cannabis, state marijuana regulators, producers, and other invested parties are wrestling with how to protect consumers, especially in a landscape where lab-testing requisites, enforcement, and broad-scale product recalls diverge dramatically across states. Presently, each state independently determines its lab testing standards for cannabis potency, contaminants, production, ...

October 4th, 2023|
  • atai Life Sciences

Atai Life Sciences and Cybin Announce Progress in Psychedelic Drug Studies

LOS ANGELES-- In a sector where every advancement is keenly watched, two significant players in the psychedelic drug industry provided the market with notable updates on their respective drug testing procedures. Atai Life Sciences Shares Phase 1 Results Atai Life Sciences confirmed the successful completion of its Phase 1 study concerning VLS-01, its proprietary DMT ...

October 4th, 2023|

Medical Cannabis Push Gains Momentum in Idaho

IDAHO — The quest to introduce medical cannabis in Idaho is gathering steam, spearheaded by the determined advocacy group, Kind Idaho. The Gem State remains one of the final holdouts in the nation without any legal form of cannabis. Driven by the ambition to legalize medical cannabis for cardholders, Kind Idaho is diligently garnering signatures ...

October 4th, 2023|

Cybin Inc. Successfully Completes Phase 2 Dosing of Promising Psilocybin Analog for Depression Treatment

NEW YORK — Cybin Inc., a psychedelic-based medical treatments, announced today the successful completion of its Phase 2 clinical trial for CYB003, a proprietary deuterated psilocybin analog. The compound is being evaluated as a potential breakthrough treatment for Major Depressive Disorder (MDD). With the trial's conclusive data expected in the latter part of this year, ...

October 3rd, 2023|

Georgia Health Officials Miscount Medical Cannabis Patients, Affecting Dispensary Plans

ATLANTA — A recent revelation by the Georgia Department of Public Health (DPH) has stirred the state’s medical cannabis industry. The DPH admitted to a significant overestimation of the number of medical cannabis patients and caregivers enrolled in its low-THC oil registry. While initial figures presented by health officials indicated approximately 50,000 registered individuals, the ...

October 3rd, 2023|

Ohio Voters Show Strong Support for November’s Cannabis Legalization Measure

COLUMBUS- As Ohio prepares for the upcoming November elections, new data reveals that the majority of the state's voters are leaning towards the approval of a cannabis legalization measure. The poll, commissioned by the Coalition to Regulate Cannabis Like Alcohol (CRMLA) and conducted by FM3 Research, offered an insight into the public sentiment regarding the ...

October 2nd, 2023|

Verano Holdings and TILT Join Forces for Breast Cancer Awareness Month

LOS ANGELES- In a commendable move, Verano Holdings Corp. is prepping for its third annual Breast Cancer Awareness Month campaign, which will commence on October 1st. This extensive initiative will span eleven states, showcasing the company's commitment to this cause. CEO George Archos spoke about the campaign with evident enthusiasm, saying, "We are proud to ...

October 1st, 2023|

American Nurses Association Recognizes Cannabis as Specialty Practice Area

LOS ANGELES- The American Nurses Association (ANA), representing over 5 million nurses in the United States, has formally recognized cannabis as a distinct nursing specialty practice. This announcement, made in a press release on Wednesday, underscores the pivotal role of cannabis nurses in offering patient education and incorporating cannabis-based treatments. Jennifer Mensik Kennedy, ANA President, ...

October 1st, 2023|

Schumer Expresses Strong Support for Cannabis Banking Reform in Senate

WASHINGTON- Senate Majority Leader Chuck Schumer (D-N.Y.) emphasized his support for cannabis banking reform during his speech on the Senate floor this Wednesday. Addressing the Senate, Schumer discussed the ongoing committee markup for the bipartisan SAFER Banking Act, a pivotal legislation designed to offer a "safe harbor" for financial institutions eager to work with the ...

September 28th, 2023|

Numinus Wellness Seeks C$10 Million Capital Injection Through Share Sale

LOS ANGELES- Vancouver's Numinus Wellness Inc., a pioneer in the psychedelics space, unveiled plans to generate an additional C$10 million through an at-the-market equity program. However, the exact count of shares to hit the market remains undetermined and hinges on the company's financier, Stifel Nicolaus Canada Inc., which has an established "equity distribution agreement" overseeing ...

September 28th, 2023|
Go to Top